Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GNG-DE meningococcal vaccine in children and adults
NCT06834100Phase 3Recruiting
- Sponsor
- Petrovax Pharm
- Start
- Feb 2025
- Primary completion
- Dec 2025
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of GNG-DE in meningococcal infection, sponsored by Petrovax Pharm. Started Feb 2025; status: recruiting.
02
Drugs
GNG-DE
03
Conditions
meningococcal infection
Beyond the preview
Go deeper on NCT06834100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06834100.